The Food and Drug Administration said Monday that it won’t require huge, months-long studies if COVID-19 vaccines eventually need tweaking to better match a mutating virus — small, short studies…

Read more »

The post FDA Will Allow Short Studies of Virus Variants appeared first on Hamodia.

In related news:

  1. Moderna Set to Start Final-Stage Vaccine Trial in 30,000 People
  2. The View From Inside ‘Overwhelmed’ California Hospitals
  3. Utah Hospital Workers Rushed to NYC to Help With Coronavirus This Spring. NYC Workers Returned the Favor.
  4. Old Meds for New Ills — Redux
  5. European Regulator Gives Green Light for AstraZeneca-Oxford COVID-19 Vaccine